supported by grants from the National Health and Medical Research Council of Australia;the National Natural Science Foundation of China(81271712);Hunan Provincial Natural Science Foundation of China(11JJ4078)
BACKGROUND: A major barrier to the clinical application of xenotransplantation as a treatment option for patients is T cell-mediated rejection. Studies based on experimental rodent models of xenograft tolerance or rej...